Heterogeneity in limb fatty acid kinetics in type 2 diabetes

scientific article published on 14 April 2005

Heterogeneity in limb fatty acid kinetics in type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00125-005-1727-1
P698PubMed publication ID15830181
P5875ResearchGate publication ID7907257

P50authorBengt SaltinQ817238
Massimo SacchettiQ38799212
Gerrit van HallQ42260000
P2093author name stringD B Olsen
P2860cites workMolecular mechanisms regulating hormone-sensitive lipase and lipolysisQ28187666
Marked heterogeneity of human skeletal muscle lipolysis at restQ28216137
Effects of fat on insulin-stimulated carbohydrate metabolism in normal menQ28332980
Skeletal muscle substrate metabolism during exercise: methodological considerationsQ33921958
Interaction between glucose and free fatty acid metabolism in human skeletal muscleQ34110324
Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitusQ34118784
Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistanceQ34248434
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.Q34543330
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistanceQ34577169
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.Q34655571
Fatty acid transport across membranes: relevance to nutrition and metabolic pathologyQ34676034
Regulation of fatty acid transport and membrane transporters in health and diseaseQ35024439
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitusQ35824553
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.Q41275648
Lipolysis: contribution from regional fat.Q41548512
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjectsQ42439893
Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid statusQ42452350
Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubesQ42457784
Systemic and regional free fatty acid metabolism in type 2 diabetesQ43606126
Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivoQ43651822
Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscleQ43704179
The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjectsQ43901633
Measurements of interstitial muscle glycerol in normal and insulin-resistant subjectsQ43982464
Regional fat metabolism in human splanchnic and adipose tissues; the effect of exerciseQ44136843
Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recoveryQ44136847
Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36.Q44155596
Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapyQ44328964
Regulation and Counterregulation of Lipolysisin Vivo: Different Roles of Sympathetic Activation and InsulinQ44645605
Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistanceQ44685960
Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes.Q44745121
Regulation of Non-esterified Fatty Acid and Glycerol Concentration by Insulin in Normal Individuals and Patients with Type 2 DiabetesQ46204188
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.Q46624327
Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects.Q51554886
Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.Q51555112
Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.Q51561168
Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo.Q51565294
Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans.Q54031382
Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin.Q54074992
Insulin regulation of regional free fatty acid metabolism.Q54108262
Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humansQ67301241
Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle massQ68158147
Insulin-Stimulated Muscle Glucose Clearance in Patients With NIDDM: Effects of One-Legged Physical TrainingQ72015336
Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichmentQ73160600
Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humansQ73807134
Influences of glucose loading and of injected insulin on hepatic glucose outputQ79273897
P433issue5
P921main subjectfatty acidQ61476
heterogeneityQ928498
P304page(s)938-945
P577publication date2005-04-14
P1433published inDiabetologiaQ5270140
P1476titleHeterogeneity in limb fatty acid kinetics in type 2 diabetes
P478volume48

Reverse relations

cites work (P2860)
Q83735429Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes?
Q37719599Arm and leg substrate utilization and muscle adaptation after prolonged low-intensity training.
Q57300532Association of Thigh Muscle Mass with Insulin Resistance and Incident Type 2 Diabetes Mellitus in Japanese Americans
Q46387227Glucose clearance is higher in arm than leg muscle in type 2 diabetes
Q38463986Neuromuscular dysfunction in type 2 diabetes: underlying mechanisms and effect of resistance training.
Q57788974Normal mitochondrial function and increased fat oxidation capacity in leg and arm muscles in obese humans
Q34706087Regulation of PDH in human arm and leg muscles at rest and during intense exercise.
Q57580397Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery
Q37332560Thigh circumference and risk of heart disease and premature death: prospective cohort study